Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
06/2010
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2448741C Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
06/22/2010CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
06/17/2010WO2010068717A2 Pyrazolinone scavengers of free radicals
06/17/2010WO2010068242A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/17/2010WO2010066829A1 Process for obtaining enantiomerically enriched pyrazole derivatives
06/17/2010WO2010066682A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/17/2010WO2010066658A1 Compounds which potentiate the ampa receptor and uses thereof in medicine
06/17/2010WO2010048207A3 Aryl gpr120 receptor agonists and uses thereof
06/17/2010US20100152443 Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient
06/17/2010US20100152266 Iodopyrazolyl Carboxanilides
06/17/2010US20100152265 Indazole derivatives
06/17/2010US20100152260 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
06/17/2010US20100152252 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
06/17/2010US20100152185 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
06/17/2010US20100152154 Novel platinum compounds for treating cancer
06/17/2010US20100152125 Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases
06/17/2010US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
06/17/2010US20100150899 Pyrazolinone scavengers of free radical
06/17/2010CA2745843A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/17/2010CA2744124A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/16/2010EP2196458A1 Process for obtaining enantiomerically enriched pyrazole derivatives
06/16/2010EP2195301A1 Crystalline chemotherapeutic
06/16/2010EP2195300A1 Crystalline chemotherapeutic
06/16/2010EP2195299A1 Crystalline chemotherapeutic
06/16/2010EP2195298A1 Crystalline indazole-derived chemotherepeutic
06/16/2010EP2195297A1 Crystalline chemotherapeutic
06/16/2010CN1889949B PDK-1/Akt signaling inhibitors
06/16/2010CN1871221B N-substituted pyrazolyl carboxanilides
06/16/2010CN1863806B 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
06/16/2010CN1830978B Pyrazolo [4,3-c]-quinolin-3-one compound, preparation method and use thereof
06/16/2010CN1393446B 稠合吡唑化合物 Fused pyrazole compounds
06/16/2010CN101743230A Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
06/16/2010CN101743226A Inhibitors of 11beta-hydroxysteroid dehydrogenase
06/16/2010CN101743225A Novel crystalline form of 3-(difluormethyl)-1-methyl-n -(3',4',5'-trifluor[1,1'-biphenyl]-2-yl)-1h-pyrazol-4-carboxamide
06/16/2010CN101735151A Crystalline form I of lonidamine, preparation method thereof and composite containing the same
06/16/2010CN101735150A Thiourea derivatives containing pyrromonazole ring, preparation method and use thereof
06/15/2010US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury
06/15/2010US7737236 Electroconductive polymers, for use in electroluminescent diodes for displays in mobile telephones or for visual display units in computers
06/15/2010US7737156 6-(Cyclohexylmethyl)-1-(1-ethylpropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, administered to humans or animals, to improve perception, concentration, cognition, learning and/or memory, as a consequence of dementia, stroke, brain trauma, Alzheimer's disease, Parkinson's disease or depression
06/15/2010US7737149 Heterocyclic amides as anticancer agents
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
06/15/2010CA2441309C Biguanide derivatives
06/10/2010WO2010064875A2 Novel indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
06/10/2010WO2010027875A3 Compounds that modulate intracellular calcium
06/10/2010US20100145042 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
06/10/2010US20100144818 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
06/10/2010US20100144817 Fungicidel n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n'-substituted-amidine derivatives
06/10/2010US20100144812 Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production Containing an Azole
06/10/2010US20100144798 Modulators of ATP-Binding Cassette Transporters
06/10/2010US20100144785 Fungicide n-6-membered fused (hetero) aryl-methylene-n-cycloalkyl carboxamide derivatives
06/10/2010US20100144747 1h-quinaz0line-2,4-diones
06/09/2010EP2194045A1 Substituted pyrazole derivative
06/09/2010EP2192900A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
06/09/2010EP1730115B1 5-aminoalkylpyrazole derivatives as pesticidal agents
06/09/2010CN101730683A Indane-amine derivatives, their preparation and use as medicaments
06/09/2010CN101723898A Method for preparing 5-amino-3-cyano-1-(2,6-dichloro-4-trifluoromethyl)-4-trifluoromethyl sulfinyl pyrazol
06/08/2010US7732475 Substituted pyrazoles, indazoles, 1,2,3-triazoles, or benzotriazoles; anticarcinogenic agents, antiinflammatory agents, antiarthritic agents, transplant rejection; controlled release formulations; aralkylation and amidation of the indazole compound
06/08/2010US7732375 anilide fungicides such as 1,3,5-trimethyl-N-[2-(1,3,3-trimethylbutyl)phenyl]-1H-pyrazole-4-carboxamide, used for controlling unwanted microorganisms
06/03/2010WO2010062321A1 Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
06/03/2010WO2010060379A1 Ether compounds with nitrogen-containing 5-member heterocycle and the uses thereof
06/03/2010WO2010060214A1 Hybrid -ionone and curcumin molecules as anticancer agents
06/03/2010WO2010015657A3 Alkoxypyrazoles and the process for their preparation
06/03/2010WO2010015656A3 Alkoxypyrazoles and the process for their preparation
06/03/2010WO2009109654A8 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
06/03/2010WO2009061652A8 Compounds which modulate the cb2 receptor
06/03/2010US20100137599 Process for preparing 1,4-butandiol monitrate
06/03/2010US20100137395 Process for the Sulfinylation of a Pyrazole Derivative
06/03/2010US20100137394 Pyrazole inhibitors of wnt signaling
06/03/2010US20100137338 INHIBITORS OF Akt ACTIVITY
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137322 Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010CA2744360A1 Hybrid -ionone and curcumin molecules as anticancer agents
06/02/2010EP2192116A1 Indazole acrylic acid amide compound
06/02/2010EP2192115A1 1,3-dimethylbutylcarboxanilides for controlling undesirable micro-organisms
06/02/2010EP2190822A2 5-membered heterocyclic compounds as proton pump inhibitors
06/02/2010EP2190821A1 Fluorine-containing organosulfur compound and pesticidal composition comprising the same
06/02/2010EP2190293A1 Compounds and methods for treating zinc matrix metalloprotease dependent diseases
06/02/2010EP1417200B1 Substituted 1h-dihydropyrazoles, their preparation and use
06/02/2010EP1416797B1 Arthropodicidal anthranilamides
06/02/2010CN1809559B Pyrazole derivatives as phosphodiesterase 4 inhibitors
06/02/2010CN101720317A Method for producing difluoromethyl-substituted pyrazole compounds
06/01/2010US7728030 novel indazolyl ester or amide derivatives; N-((1S,2R)-2-{[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy}-1-methyl-2-phenylethyl)cyclopropanecarboxamide; non-steroidal compounds as modulators of the glucocorticoid receptor; acylation
06/01/2010US7728029 hydroxysteroid reductase inhibitors such as 2'-tert-butyl-2'H-[1,3']bipyrazolyl-4'-carboxylic acid (5-hydroxy-adamantan-2-yl)-amide, used for the treatment of non-insulin dependent diabetes mellitus and metabolic syndrome
06/01/2010US7728022 (4, 5, 6, 7-tetrahydro-1-H-indol-7-yl) acetic acid derivatives for treatment of Alzheimer's disease
06/01/2010US7728019 Biphenylcarboxamides
06/01/2010US7728018 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonists
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010CA2352524C Aromatic heterocyclic compounds as antiinflammatory agents
05/2010
05/27/2010WO2010059719A2 Dimeric 1-arylpyrazole derivatives
05/27/2010WO2010059241A2 Treatment of amyotrophic lateral sclerosis
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058314A1 Hydroxyquinolin-2(1h)-ones and derivatives thereof
05/27/2010WO2010018213A3 Spiroimidazole compounds suitable for the treatment of neurological disorders
05/27/2010WO2010000372A3 New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
05/27/2010WO2009140624A3 Glucokinase activators
05/27/2010US20100130743 Heterocycle-substituted, n-phenyl-phthalamide derivatives, related compounds and their use as insecticides
05/27/2010US20100130538 Bicyclic compound and pharmaceutical use thereof
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 256